Discover how Clinical ink is advancing Alzheimer's research by supporting 16th concurrent clinical trials in 25 countries, involving over 9,000 patients.
Newsroom
WILMINGTON, N.C. (March 22, 2021) – PPD, Inc. (Nasdaq: PPD), a leading global contract research organization, and Clinical ink, a global clinical …
HORSHAM, Pa.; Dec. 10, 2020 – Clinical ink, a global clinical trial technology company, today announced five years of providing clients with …
HORSHAM, Pa.; Dec. 3, 2020 – Clinical ink, a global clinical trial technology company, today announced an investment from McKesson Ventures alongside its significantly enhanced electronic patient reported outcome (ePRO) …
Horsham, Pa.; Aug. 4, 2020 – Clinical ink, a global clinical trial technology company, today announced its acquisition by GI Partners, a …
Horsham, Pa.; June 2, 2020 – Clinical Ink, a global clinical trial technology company, has helped expedite the study of a treatment …
Horsham, Pa.; April 29, 2020 – Clinical Ink, a global clinical trial technology company, has announced a wide-ranging Study Assurance Program to …
Horsham, Pa.; April 14, 2020 – Clinical Ink, a global clinical trial technology company, has made a commitment to donate several hundred mobile phones …
